HY-N2558-1mg
|
MedChemexpress LLC
|
Mu rrayone [CAS 19668-69-0]
|
|
Cancer-programmed cell death
|
|
HY-N2558-10mg
|
MedChemexpress LLC
|
Mu rrayone [CAS 19668-69-0]
|
|
Cancer-programmed cell death
|
|
HY-N2558-5mg
|
MedChemexpress LLC
|
Mu rrayone [CAS 19668-69-0]
|
|
Cancer-programmed cell death
|
|
HY-F0003-100mg
|
MedChemexpress LLC
|
NADPH (tetrasodium salt) [CAS 2646-71-1]
|
|
Cancer-programmed cell death
|
|
HY-F0003-50mg
|
MedChemexpress LLC
|
NADPH (tetrasodium salt) [CAS 2646-71-1]
|
|
Cancer-programmed cell death
|
|
HY-F0003-1mL
|
MedChemexpress LLC
|
NADPH (tetrasodium salt) [CAS 2646-71-1] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-P701027-100ug
|
MedChemexpress LLC
|
NLRP3, Human (GST)
|
|
|
|
HY-P701027-20ug
|
MedChemexpress LLC
|
NLRP3, Human (GST)
|
|
|
|
HY-P701027-50ug
|
MedChemexpress LLC
|
NLRP3, Human (GST)
|
|
|
|
HY-144223-10mg
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-2 [CAS 791840-86-3]
|
|
COVID-19-immunoregulation
|
|
HY-144223-100mg
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-2 [CAS 791840-86-3]
|
|
COVID-19-immunoregulation
|
|
HY-144223-25mg
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-2 [CAS 791840-86-3]
|
|
COVID-19-immunoregulation
|
|
HY-144223-5mg
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-2 [CAS 791840-86-3]
|
|
COVID-19-immunoregulation
|
|
HY-144223-50mg
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-2 [CAS 791840-86-3]
|
|
COVID-19-immunoregulation
|
|
HY-144223-1mL
|
MedChemexpress LLC
|
NLRP3/AIM2-IN-2 [CAS 791840-86-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-N7434-500mg
|
MedChemexpress LLC
|
N-Nitrosodiethylamine [CAS 55-18-5]
|
|
Cancer-programmed cell death
|
|
HY-N7434-1mL
|
MedChemexpress LLC
|
N-Nitrosodiethylamine [CAS 55-18-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-N7434S1-1mg
|
MedChemexpress LLC
|
N-Nitrosodiethylamine-d10 [CAS 1219794-54-3]
|
|
Cancer-programmed cell death
|
|
HY-N7434S1-10mg
|
MedChemexpress LLC
|
N-Nitrosodiethylamine-d10 [CAS 1219794-54-3]
|
|
Cancer-programmed cell death
|
|
HY-N7434S1-5mg
|
MedChemexpress LLC
|
N-Nitrosodiethylamine-d10 [CAS 1219794-54-3]
|
|
Cancer-programmed cell death
|
|
HY-N7434S-1mg
|
MedChemexpress LLC
|
N-Nitrosodiethylamine-d4 [CAS 1346603-41-5]
|
|
Cancer-programmed cell death
|
|
HY-N6777-1mg
|
MedChemexpress LLC
|
Penicillic acid [CAS 90-65-3]
|
|
Cancer-programmed cell death
|
|
HY-N6777-10mg
|
MedChemexpress LLC
|
Penicillic acid [CAS 90-65-3]
|
|
Cancer-programmed cell death
|
|
HY-N6777-5mg
|
MedChemexpress LLC
|
Penicillic acid [CAS 90-65-3]
|
|
Cancer-programmed cell death
|
|
HY-N6777-1mL
|
MedChemexpress LLC
|
Penicillic acid [CAS 90-65-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|